Dr. Lipscombe is a Professor in the Department of Medicine and the Dalla Lana School of Public Health at the University of Toronto, as well as a clinician scientist and endocrinologist at Women’s College Hospital. Dr. Lipscombe is also the Executive Director of the University of Toronto’s Novo Nordisk Network for Healthy Populations, which is a cross-disciplinary research network that aims to address the burden of diabetes and other chronic diseases with a focus on the Ontario Region of Peel.

Dr. Lipscombe received her MD from McGill University, followed by training in Internal Medicine and Endocrinology and a Master’s in Clinical Epidemiology, at University of Toronto. Dr. Lipscombe leads an internationally recognized research program in diabetes epidemiology and health services, with a particular focus on health services for the management and prevention of diabetes in women. She has published over 150 peer-reviewed articles, and has held numerous grants and career awards from CIHR and Diabetes Canada, where she currently serves on the Board of Directors.

Dr. Anne-Sophie Brazeau is an Assistant Professor and Director of the Dietetics Education and Practice program in the School of Human Nutrition in the Faculty of Agricultural and Environmental Sciences at McGill University. She is a Fonds de recherche du Québec- Santé (FRQS) chercheur boursier Junior 1 (2021-2025) and a registered dietitian, member of the Ordre des Diététistes Nutritionnistes du Québec (ODNQ). She started her career working in Clinical Nutrition in a University Hospital mainly managing patients with chronic disease. Her interest in improving the long-term health of her patients with diabetes led her to pursue graduate studies in Nutrition.

Her research program builds on patients’ experience and needs. It was informed by patient-partners with whom she works closely. It aims to: 1) understand the patients’ experience with diabetes self-management, 2) inform on diet and eating behaviors in type 1 diabetes in the context of contemporary diabetes therapies, 3) and explore strategies for timely access to diabetes education and support, in both adolescents and adults. She leads a national prospective registry of patients living with type 1 diabetes in Canada, the BETTER registry (www.type1better.ca). Her research projects have been funded by numerous organizations such the Canadian Institutes for Health Research, Diabetes Canada, Diabète Québec and the Société Francophone du Diabète.

Rayzel Shulman is a Pediatric Endocrinologist in the Division of Endocrinology, Department of Pediatrics at The Hospital for Sick Children. She is an Associate Professor of Pediatrics at the University of Toronto. She is a Scientist in the Child Health and Evaluative Sciences Program at the Sickkids Research Institute and an Adjunct Scientist at ICES.  

Her research program is focused on developing and evaluating health services interventions to improve health outcomes and the quality of care for youth living with diabetes. She is particularly interested in developing and evaluating interventions that leverage existing population-level administrative datasets to inform health system change. Areas of focus include transition to adult care, prevention of diabetic ketoacidosis at diagnosis, incidence of pediatric diabetes since the COVID-19 pandemic, and reducing socioeconomic disparities in diabetes management and outcomes.

Holly has lived with T1D since she was diagnosed as a child in 1983 in Regina, Saskatchewan. She is now a Professor of Medicine in the Faculty of Medicine at Université Laval. She is the Canada Research Chair in Human-Centred Digital Health, and a Scientist at the Vitam Research Centre in Sustainable Health in Quebec City, Quebec. During her 41+ years with T1D, she has lived through a diverse range of medication and technology availability and unavailability. She is committed to this project because she believes that everyone with T1D should have access to the tools and support they wish to use to make their lives easier.

Dr. Ananya Tina Banerjee is Assistant Professor and the Equity, Diversity, Inclusion and Anti-Racism (EDIAR) Lead at the School of Population & Global Health, Faculty of Medicine and Health Sciences, McGill University. Her interdisciplinary epidemiologic, qualitative and intervention research embeds a strong emphasis on community-based approaches, which is grounded in partnership with South Asian diaspora communities at high risk for type 2 diabetes in Canada. Often, the research questions she pursues are South Asian community-defined problems in the context of racism and health equity funded by the Canadian Institute of Health Research, Social Science & Humanities Research Council and Public Health Agency of Canada. She served on the Editorial Board for the Canadian Journal of Diabetes from 2021-2023 and co-led the Special Issue on the Social Determinants of Diabetes. Currently, she serves on The Lancet’s International Advisory Board for Racial Inequalities.

Dr. Presseau is a Senior Scientist at the Clinical Epidemiology Program, Ottawa Hospital Research Institute and Associate Professor in the School of Epidemiology & Public Health and School of Psychology at the University of Ottawa. As a behavioural scientist, he leads the Psychology and Health Research Group (PaHRG) and is a core faculty member of the Centre for Implementation Research at the Ottawa Hospital. He holds a Ph.D. in Psychology from the University of Aberdeen (UK). His research program operates at the intersection between behavioural science and implementation science, focusing on developing and evaluating interventions to support changing healthcare professional behaviours and health behaviours of patients and the public.

Dr. Nakhla is a Pediatric Endocrinologist, Associate Professor of Pediatrics and Fonds de recherche du Québec – Santé (FRQS) Clinician Scientist at the Montreal Children’s Hospital, McGill University. Her research focuses on healthcare access and use in children and adolescents with type 1 diabetes. The results of her studies aim to identify the healthcare needs of children and youth with diabetes and ultimately help to inform how best to deliver diabetes care, including transition care for adolescents. She is the recipient of FRQS Senior Clinician Scientist Salary Award and operating grants from FRQS, Diabetes Canada and Canadian Institutes of Health Research (CIHR).

Rémi Rabasa-Lhoret is vice-president (clinical and clinical research) at the IRCM, medical doctor in the endocrinology division of the CHUM, professor of medicine and nutrition at the University of Montreal. He holds 3 diabetes research chairs and has received numerous awards and fellowships. His team holds large national and international funds, has published over 400 manuscripts, contributed to national and international treatment recommendations. He is also director of the professional section of diabetes Québec and a member of the Canadian Academy of Health Sciences. The main objective of his team's research program is to reduce the burden of hypoglycemia for patients with type 1 diabetes. He was one of the pioneers in the development of the artificial pancreas. He also studies the causes and consequences of diabetes in patients living with cystic fibrosis.

Dr. Joyce Dogba is trained as a physician in Togo. She holds a master’s degree in health economics and a PhD in Public Health. She is currently a full professor in the Department of Family and Emergency Medicine at Laval University. Her research agenda comprises evaluation of collaborative practices with patients-users in research and the education of health professionals.  Joyce Dogba is a co-lead on patient engagement within the SRAP/SPOR Network in Diabetes and Related Complications.

Erik completed his PhD in Biostatistics from the Dalla Lana School of Public Health at the University of Toronto in 2022. He is currently the principal biostatistician in the Biostatistics Department at the University Health Network. His research interests lie in joint models for longitudinal and survival data and in dynamic prediction modelling and evaluation. He has a keen interest in applying these methods to inform our understanding of diabetes.